Synthego at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Synthego brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on supplying CRISPR reagents that can follow a programme from research into the clinic. Topics include a stage-appropriate approach to reagent manufacturing and a GMP-grade cytosine base editor supplied as protein.

OrganizationESGCT 2026 Attendance
Synthego
Redwood City, California
synthego.com
Tools & reagents
Supplies synthetic guide RNAs, CRISPR-edited cells and GMP-grade gene editing reagents for research and clinical programs.
Poster
Wed Oct 28
1:30pm–3:30pm
Building a Scalable Path from Research to Commercialization: A Stage-Appropriate Approach to CRISPR Reagent Manufacturing
Gene Editing
Poster
Thu Oct 29
2:00pm–4:00pm
AccuBase™: A GMP-grade protein-format Cytosine Base Editor (CBE) enabling safer, high-performance gene editing
Gene Editing

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Synthego

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction